Direct-to-consumer genetic testing: User motivations, decision making, and perceived utility of results

J. Scott Roberts, Michele C. Gornick, Deanna Alexis Carere, Wendy R. Uhlmann, Mack Ruffin, Robert C. Green

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background/Aims: To describe the interests, decision making, and responses of consumers of direct-to-consumer personal genomic testing (DTC-PGT) services. Methods: Prior to 2013 regulatory restrictions on DTC-PGT services, 1,648 consumers from 2 leading companies completed Web surveys before and after receiving test results. Results: Prior to testing, DTC-PGT consumers were as interested in ancestry (74% very interested) and trait information (72%) as they were in disease risks (72%). Among disease risks, heart disease (68% very interested), breast cancer (67%), and Alzheimer disease (66%) were of greatest interest prior to testing. Interest in disease risks was associated with female gender and poorer self-reported health (p < 0.01). Many consumers (38%) did not consider the possibility of unwanted information before purchasing services; this group was more likely to be older, male, and less educated (p < 0.05). After receiving results, 59% of respondents said test information would influence management of their health; 2% reported regret about seeking testing and 1% reported harm from results. Conclusion: DTC-PGT has attracted controversy because of the health-related information it provides, but nonmedical information is of equal or greater interest to consumers. Although many consumers did not fully consider potential risks prior to testing, DTC-PGT was generally perceived as useful in informing future health decisions.

Original languageEnglish (US)
Pages (from-to)36-45
Number of pages10
JournalPublic health genomics
Volume20
Issue number1
DOIs
StatePublished - Jun 1 2017

Fingerprint

Genetic Testing
Motivation
Decision Making
Health
Heart Diseases
Alzheimer Disease
Emotions
Breast Neoplasms
Direct-To-Consumer Screening and Testing
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Genetics(clinical)

Cite this

Roberts, J. Scott ; Gornick, Michele C. ; Carere, Deanna Alexis ; Uhlmann, Wendy R. ; Ruffin, Mack ; Green, Robert C. / Direct-to-consumer genetic testing : User motivations, decision making, and perceived utility of results. In: Public health genomics. 2017 ; Vol. 20, No. 1. pp. 36-45.
@article{3fae05ea7ad44fd79fc96d4ba4d8ae55,
title = "Direct-to-consumer genetic testing: User motivations, decision making, and perceived utility of results",
abstract = "Background/Aims: To describe the interests, decision making, and responses of consumers of direct-to-consumer personal genomic testing (DTC-PGT) services. Methods: Prior to 2013 regulatory restrictions on DTC-PGT services, 1,648 consumers from 2 leading companies completed Web surveys before and after receiving test results. Results: Prior to testing, DTC-PGT consumers were as interested in ancestry (74{\%} very interested) and trait information (72{\%}) as they were in disease risks (72{\%}). Among disease risks, heart disease (68{\%} very interested), breast cancer (67{\%}), and Alzheimer disease (66{\%}) were of greatest interest prior to testing. Interest in disease risks was associated with female gender and poorer self-reported health (p < 0.01). Many consumers (38{\%}) did not consider the possibility of unwanted information before purchasing services; this group was more likely to be older, male, and less educated (p < 0.05). After receiving results, 59{\%} of respondents said test information would influence management of their health; 2{\%} reported regret about seeking testing and 1{\%} reported harm from results. Conclusion: DTC-PGT has attracted controversy because of the health-related information it provides, but nonmedical information is of equal or greater interest to consumers. Although many consumers did not fully consider potential risks prior to testing, DTC-PGT was generally perceived as useful in informing future health decisions.",
author = "Roberts, {J. Scott} and Gornick, {Michele C.} and Carere, {Deanna Alexis} and Uhlmann, {Wendy R.} and Mack Ruffin and Green, {Robert C.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1159/000455006",
language = "English (US)",
volume = "20",
pages = "36--45",
journal = "Public Health Genomics",
issn = "1662-4246",
publisher = "S. Karger AG",
number = "1",

}

Direct-to-consumer genetic testing : User motivations, decision making, and perceived utility of results. / Roberts, J. Scott; Gornick, Michele C.; Carere, Deanna Alexis; Uhlmann, Wendy R.; Ruffin, Mack; Green, Robert C.

In: Public health genomics, Vol. 20, No. 1, 01.06.2017, p. 36-45.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Direct-to-consumer genetic testing

T2 - User motivations, decision making, and perceived utility of results

AU - Roberts, J. Scott

AU - Gornick, Michele C.

AU - Carere, Deanna Alexis

AU - Uhlmann, Wendy R.

AU - Ruffin, Mack

AU - Green, Robert C.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background/Aims: To describe the interests, decision making, and responses of consumers of direct-to-consumer personal genomic testing (DTC-PGT) services. Methods: Prior to 2013 regulatory restrictions on DTC-PGT services, 1,648 consumers from 2 leading companies completed Web surveys before and after receiving test results. Results: Prior to testing, DTC-PGT consumers were as interested in ancestry (74% very interested) and trait information (72%) as they were in disease risks (72%). Among disease risks, heart disease (68% very interested), breast cancer (67%), and Alzheimer disease (66%) were of greatest interest prior to testing. Interest in disease risks was associated with female gender and poorer self-reported health (p < 0.01). Many consumers (38%) did not consider the possibility of unwanted information before purchasing services; this group was more likely to be older, male, and less educated (p < 0.05). After receiving results, 59% of respondents said test information would influence management of their health; 2% reported regret about seeking testing and 1% reported harm from results. Conclusion: DTC-PGT has attracted controversy because of the health-related information it provides, but nonmedical information is of equal or greater interest to consumers. Although many consumers did not fully consider potential risks prior to testing, DTC-PGT was generally perceived as useful in informing future health decisions.

AB - Background/Aims: To describe the interests, decision making, and responses of consumers of direct-to-consumer personal genomic testing (DTC-PGT) services. Methods: Prior to 2013 regulatory restrictions on DTC-PGT services, 1,648 consumers from 2 leading companies completed Web surveys before and after receiving test results. Results: Prior to testing, DTC-PGT consumers were as interested in ancestry (74% very interested) and trait information (72%) as they were in disease risks (72%). Among disease risks, heart disease (68% very interested), breast cancer (67%), and Alzheimer disease (66%) were of greatest interest prior to testing. Interest in disease risks was associated with female gender and poorer self-reported health (p < 0.01). Many consumers (38%) did not consider the possibility of unwanted information before purchasing services; this group was more likely to be older, male, and less educated (p < 0.05). After receiving results, 59% of respondents said test information would influence management of their health; 2% reported regret about seeking testing and 1% reported harm from results. Conclusion: DTC-PGT has attracted controversy because of the health-related information it provides, but nonmedical information is of equal or greater interest to consumers. Although many consumers did not fully consider potential risks prior to testing, DTC-PGT was generally perceived as useful in informing future health decisions.

UR - http://www.scopus.com/inward/record.url?scp=85009361994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009361994&partnerID=8YFLogxK

U2 - 10.1159/000455006

DO - 10.1159/000455006

M3 - Article

C2 - 28068660

AN - SCOPUS:85009361994

VL - 20

SP - 36

EP - 45

JO - Public Health Genomics

JF - Public Health Genomics

SN - 1662-4246

IS - 1

ER -